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Ca
ReOBJECTIVES This study investigated the impact of ﬁnal kissing ballooning (FKB) after main vessel (MV) stenting
on outcomes in patients with coronary bifurcation lesions after application of the 1-stent technique.
BACKGROUND Although FKB has been established as the standard method for bifurcation lesions treated with a
2-stent strategy, its efﬁcacy in a 1-stent approach is highly controversial.
METHODS This study enrolled 1,901 patients with a bifurcation lesion with a side branch diameter $2.3 mm, treated
solely with the 1-stent technique using a drug-eluting stent from 18 centers in Korea between January 1, 2003 and
December 31, 2009. The primary outcome was major adverse cardiac events (MACE)—cardiac death, myocardial infarc-
tion, or target lesion revascularization. Propensity score-matching analysis was also performed.
RESULTS FKB was performed in 620 patients and the post minimal lumen diameter of the MV and side branch was
larger in the FKB group than in the non-FKB group. During follow-up (median 36 months), the incidence of MACE
(adjusted hazard ratio [HR]: 0.68, 95% conﬁdence interval [CI]: 0.46 to 0.99; p ¼ 0.048) was lower in the FKB group
than the non-FKB group. After propensity score matching (545 pairs), the FKB group had a lower incidence of MACE
(adjusted HR: 0.50, 95% CI: 0.30 to 0.85; p ¼ 0.01), and target lesion revascularization in the MV (adjusted HR: 0.51,
95% CI: 0.28 to 0.93; p ¼ 0.03) and both vessels (adjusted HR: 0.47, 95% CI: 0.25 to 0.90; p ¼ 0.02) than in the
non-FKB group.
CONCLUSIONS In coronary bifurcation lesions, we demonstrated that the 1-stent technique with FKB was associated
with a favorable long-term clinical outcome, mainly driven by the reduction of target lesion revascularization in the
MV or both vessels as a result of an increase in minimal lumen diameter. (Korean Coronary Bifurcation Stenting Registry II
[COBIS II]: NCT01642992) (J Am Coll Cardiol Intv 2015;8:1297–307) © 2015 by the American College of Cardiology
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rdiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,
public of Korea; zDivision of Cardiology, Sejong General Hospital, Bucheon, Republic of Korea; xSamsung Changwon Hospital,
ABBR EV I A T I ON S
AND ACRONYMS
CI = conﬁdence interval
FKB = ﬁnal kissing ballooning
HR = hazard ratio
MACE = major adverse
cardiac event(s)
MI = myocardial infarction
MLD = minimal luminal
diameter
MV = main vessel
PCI = percutaneous coronary
intervention
QCA = quantitative coronary
angiography
RD = reference diameter
SB = side branch
TLR = target lesion
revascularization
Sungkyunk
Republic o
Daejeon, R
Yonsei Un
Republic o
relationship
Manuscript
Yu et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5
Final Kissing Ballooning in Coronary Bifurcation Lesion A U G U S T 2 4 , 2 0 1 5 : 1 2 9 7 – 3 0 7
1298P rovisional stenting of the side branch(SB) after main vessel (MV) stenting isnow a standard approach to coronary
bifurcation lesions because the elective 2-
stent technique offers few advantages over
the 1-stent technique (1–3). In addition, the
2-stent technique has been associated with
increased use of contrast, longer procedure
time, and higher rates of procedure-related
myocardial infarction (1,4). Although ﬁnal
kissing ballooning (FKB) is currently consid-
ered mandatory in 2-stent techniques such
as culotte and crush approaches (5,6), the
effects of FKB on clinical and angiographic
outcomes after only MV stenting are contro-
versial (7,8). Randomized trials have found
no short-term or long-term beneﬁts of FKB
(2,9), and a retrospective study reported
harmful effects of FKB with the 1-stent tech-
nique (7). However, most relevant studiesare limited by small sample size, an inadequate
short-term follow-up period, exclusion of left main
bifurcation lesions, or a small SB. Therefore, we
investigated whether routine FKB after successful
stenting of the MV would improve long-term out-
comes in patients with coronary bifurcation lesions,
including left main bifurcation lesions, in a large-
scale, multicenter registry.
METHODS
STUDY POPULATION. The COBIS II (Korean Coronary
Bifurcation Stenting Registry) is a retrospective
multicenter registry of individuals with coronary
bifurcation lesions who underwent percutaneous
coronary intervention (PCI) with a drug-eluting stent.
We enrolled patients from 18 major coronary inter-
vention centers in Korea between January 1, 2003 and
December 31, 2009. Only patients with a coronary
bifurcation lesion treated solely with drug-eluting
stents, an MV diameter $2.5 mm, and an SB
diameter $2.3 mm conﬁrmed by core lab quantitative
coronary angiography (QCA) analysis were included.
Patients with cardiogenic shock, any experience with
cardiopulmonary resuscitation, or protected left mainwan University School of Medicine, Changwon, Republic of K
f Korea; {Korea University Guro Hospital, Seoul, Republic of
epublic of Korea; **Chonnam National University Hospital, Gw
iversity Wonju College of Medicine, Wonju, Republic of Kore
f Korea; and the xxAjou University Hospital, Suwon, Republic of
s relevant to the contents of this paper to disclose. Drs. Yu an
received January 5, 2015; revised manuscript received March 25disease were excluded. This registry was sponsored
by the Korean Society of Interventional Cardiology.
The local institutional review board at each hospital
approved this study and waived the requirement
for informed consent in all enrolled patients.
To assess the effects of FKB after MV stenting on
clinical outcomes in patients undergoing the provi-
sional approach, we selected patients treated with
the 1-stent technique for 1 bifurcation lesion included
in the COBIS II database (n ¼ 2,127). Experienced
investigators (H.C.G. and J.H.Y.) conﬁrmed whether
to do FKB by reviewing all patient angiograms. We
excluded cases with total occlusion in the SB before
MV stenting (n ¼ 88), a bail-out SB intervention for
Thrombolysis In Myocardial Infarction (TIMI) ﬂow
grade <3 (n ¼ 134), or a dissection classiﬁed as type B
or worse (n ¼ 4) in the SB after MV stenting. Finally,
1,901 patients who met the selection criteria were
included in this analysis (Figure 1).
PERCUTANEOUS CORONARY INTERVENTION PROCEDURE.
All patients received loading doses of aspirin
(300 mg) and clopidogrel (300 to 600 mg) before the
coronary intervention unless they had previously
received these antiplatelet medications. Antico-
agulation therapy during PCI was performed accord-
ing to current practice guidelines stipulated by the
Korean Society of Interventional Cardiology. The
treatment strategy, stenting techniques, selection of
drug-eluting stent type, and use of glycoprotein
IIb/IIIa receptor inhibitors or intravascular ultrasound
were all left to the operator’s discretion. Aspirin
was continued indeﬁnitely, and the duration of
thienopyridine treatment was also at the operator’s
discretion.
DEFINITIONS. Death was deﬁned as any post-
procedure death and was considered to be of cardiac
origin unless there was documentation of another
cause. Myocardial infarction (MI) was deﬁned as the
presence of electrocardiography ﬁndings indicative of
ischemia that were not related to the index proce-
dure, as well as chest discomfort associated with
creatinine kinase-myocardial band fraction or
troponin-T/troponin I greater than the upper limit of
normal. Target lesion revascularization (TLR) wasorea; kSeoul National University Hospital, Seoul,
Korea; #Chungnam National University Hospital,
angju, Republic of Korea; yyDivision of Cardiology,
a; zzYonsei University Severance Hospital, Seoul,
Korea. The authors have reported that they have no
d Yang contributed equally to this study.
, 2015, accepted April 23, 2015.
FIGURE 1 Scheme of Group Distribution in the Registry
1,901 patients who met the selection criteria were included in ﬁnal analysis. COBIS II ¼
Korean Coronary Bifurcation Stenting Registry II; FKB¼ ﬁnal kissing ballooning; MV ¼main
vessel; SB ¼ side branch; TIMI ¼ Thrombolysis In Myocardial Infarction.
FIGURE 2 Schematic Diagram of QCA Analysis
The quantitative coronary angiographic (QCA) analysis assessed the following: (1) MV
proximal reference diameter (RD); (2)MVdistal RD; (3) SBdistal RD; (4)MVproximalminimal
lumen diameter (MLD); (5) MV middle MLD; (6) MV distal MLD; (7) SB ostium MLD; (8) SB
distal MLD; (9) MV lesion length; and (10) SB lesion length. Abbreviations as in Figure 1.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5 Yu et al.
A U G U S T 2 4 , 2 0 1 5 : 1 2 9 7 – 3 0 7 Final Kissing Ballooning in Coronary Bifurcation Lesion
1299deﬁned as a repeat PCI of the lesion within 5 mm of
stent deployment or bypass graft surgery of the target
vessel. The peri-procedural period included the ﬁrst
48 h after PCI. Stent thrombosis was deﬁned accord-
ing to the Academic Research Consortium as deﬁnite,
probable, or possible. The timing of stent thrombosis
was classiﬁed as early (within 1 month after the index
procedure), late (between 1 month and 1 year), or very
late (after 1 year) (10). Angiographic success was
deﬁned as the achievement of residual stenosis <30%
with TIMI ﬂow grade 3 in the MV and residual
stenosis <50% with TIMI ﬂow grade 3 in the SB. Bi-
furcations were classiﬁed according to the Medina
classiﬁcation, in which the proximal MV, distal MV,
and SB components of the bifurcation are each
assigned a score of 1 or 0 depending on the presence
or absence of >50% stenosis (11). Medina classiﬁca-
tion type 1.1.1, 1.0.1, and 0.1.1 lesions were deﬁned as
true bifurcation lesions.
CLINICAL FOLLOW-UP AND ENDPOINTS. Clinical,
laboratory, procedural, angiographic, and outcome
data were collected from an Internet-based reporting
system. Additional information was gathered by
contacting general practitioners, reviewing hospital
records, and conducting telephone interviews. The
primary outcome of this study was major adverse
cardiac events (MACE) during follow-up, deﬁned as
a composite event of cardiac death, MI, or TLR. The
secondary outcomes were the individual components
of the primary endpoint, all-cause death, and stent
thrombosis.
QUANTITATIVE CORONARY ANGIOGRAPHIC ANALYSIS.
All baseline and procedural cine coronary angiograms
were analyzed quantitatively at the angiographic
core laboratory of the Cardiac and Vascular Center,
Samsung Medical Center (Seoul, Korea), using stan-
dard qualitative and quantitative analyses with an
automatic edge-detection system (Centricity CA 1000,
GE, Waukesha, Wisconsin) (12). Besides the Centricity
Cardiology CA1000, the angiography of the bifur-
cations was analyzed using the Cardiovascular Angi-
ography Analysis System (CAAS version 5.10, Pie
Medical Imaging, Maastricht, the Netherlands). QCA
was rechecked off-line by 2 experienced analysts
(H.C.G. and J.H.Y.), independent of each other. For
QCA (Figure 2), bifurcation lesions were divided into
the proximal reference, MV proximal (proximal to SB
take-off), MV middle (<5 mm distal to take-off), MV
distal, MV distal reference, SB ostial (<5 mm distal
to take-off), SB distal, and SB reference segments.
The minimal luminal diameter (MLD) and reference
diameter (RD) before and immediately after the pro-
cedure were measured in matched views. For the MV,the RD was the average of the proximal and distal
reference lumen diameters. For SB, the RD was the
distal reference lumen diameter.
STATISTICAL ANALYSIS. All values are presented as
the mean  SD or median (interquartile range).
Comparisons between continuous variables were
made using the Student t-test or the Wilcoxon
TABLE 1
Age, yrs
Male
Medical h
Diabete
Hyperte
Dyslipid
Smoking
Chronic
Family h
Previou
Previou
Previou
Previou
Periphe
Left ventr
Serum cre
Clinical pr
Stable a
Unstabl
ST-segm
Ischemi
Non–ST
Values are m
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1300rank-sum test when applicable. Categorical data were
tested using Fisher exact test or the chi-square test.
Event-free survival was estimated by the Kaplan-
Meier method and compared with the log-rank test.
The Cox proportional hazard model was used to
compare the risks of adverse cardiac events between
the FKB and the non-FKB groups. We checked log-
linearity for linear trends, Shoenfeld residual test
for proportional hazards assumption, and variance
inﬂation factor (<5) for multicollinearity in multi-
variable Cox regression. Furthermore, we tried to
include an interaction term, but no interaction terms
were statistically signiﬁcant. Propensity scores were
estimated using multiple logistic-regression analysis.
A full nonparsimonious model that included all vari-
ables in Tables 1 and 2, as well as the baseline
QCA variables in Table 3, was developed. The covar-
iate balance achieved by matching was assessed
by calculating the absolute standardized differ-
ences in covariates between the FKB and non-FKB
groups. Pairs were matched by the nearest neighbor
matching method, a greedy algorithm among patients
with an individual propensity score. An absolute
standardized difference of <10% for the measured
covariate suggests appropriate balance between the
groups. In the propensity score-matched population,Baseline Patient Characteristics
Total Population
FKB
(n ¼ 620)
Non-FKB
(n ¼ 1,281) p Value
61.8  10.1 62.3  10.2 0.30
438 (70.7) 939 (73.3) 0.22
istory
s mellitus 176 (28.4) 390 (30.4) 0.36
nsion 367 (59.2) 739 (57.7) 0.53
emia 207 (33.4) 381 (29.7) 0.11
153 (24.7) 338 (26.4) 0.43
kidney disease 12 (1.9) 42 (3.3) 0.10
istory of coronary artery disease 21 (3.4) 34 (2.7) 0.37
s history of MI 29 (4.7) 69 (5.4) 0.51
s history of PCI 87 (14.0) 147 (11.5) 0.11
s history of CABG 3 (0.5) 11 (0.9) 0.57
s history of CVA 35 (5.7) 88 (6.9) 0.31
ral vascular disease 6 (1.0) 16 (1.3) 0.59
icular ejection fraction 60.0  10.4 57.5  9.7 <0.001
atinine, mg/dl 1.10  0.89 1.10  0.84 0.871
esentation <0.001
ngina 243 (39.2) 476 (37.2)
e angina 263 (42.4) 424 (33.1)
ent elevation MI 46 (7.4) 175 (13.7)
c cardiomyopathy or silent ischemia 13 (2.1) 25 (2.0)
-segment elevation MI 55 (8.9) 181 (14.1)
ean  SD or n (%).
oronary artery bypass graft; CVA ¼ cerebrovascular accident; FKB ¼ ﬁnal kissing balloonincontinuous variables were compared with a paired
t test or the Wilcoxon signed-rank test, as appro-
priate; categorical variables were compared with
McNemar or Bowker test of symmetry, as appropriate.
The reduction in the risk of negative outcome was
compared using a stratiﬁed Cox regression model
with prognostic covariates having an absolute stan-
dardized difference >10.0%. Cumulative incidence
rates of individual clinical outcomes and composite
outcomes were estimated by the Kaplan-Meier
method and compared by the paired Prentice-
Wilcoxon test. Statistical analyses were performed
with SAS (version 9.2, SAS Institute Inc., Cary, North
Carolina). All tests were 2-tailed, and p < 0.05 was
considered statistically signiﬁcant.
RESULTS
BASELINE, ANGIOGRAPHIC, AND PROCEDURAL
CHARACTERISTICS. Overa l l populat ion . Among the
1,901 eligible patients, FKB was performed in 620
patients (32.6%). In the FKB group, angiographic
success was achieved in 514 patients (82.9%). Base-
line patient characteristics are shown in Table 1, and
angiographic and procedural characteristics are
shown in Table 2. Compared with patients in thePropensity-Matched Population
Standardized
Difference
FKB
(n ¼ 545)
Non-FKB
(n ¼ 545) p Value
Standardized
Difference
-5.1 61.8  10.1 62.4  9.9 0.90 -6.5
-5.8 379 (69.5) 384 (70.5) 0.79 -2.0
-4.6 149 (27.3) 162 (29.7) 0.42 -5.3
3.1 325 (59.6) 298 (54.7) 0.11 10.1
7.7 188 (34.5) 170 (31.2) 0.26 7.0
-4.0 131 (24.0) 140 (25.7) 0.57 -3.8
-9.7 11 (2.0) 17 (3.1) 0.35 -8.0
4.1 18 (3.3) 14 (2.6) 0.60 4.1
-3.4 25 (4.6) 25 (4.6) 0.99 0
7.4 75 (13.8) 64 (11.7) 0.34 5.8
-5.4 2 (0.4) 6 (1.1) 0.29 -10.6
-5.3 35 (6.4) 32 (5.9) 0.80 2.4
-2.9 5 (0.9) 9 (1.7) 0.42 -7.5
23.9 59.6  10.8 59.2  8.9 0.39 3.8
-0.8 1.09  0.86 1.11  0.98 0.917 -2.1
0.71
218 (40.0) 214 (39.3)
18.8 219 (40.2) 212 (38.9) 2.6
-23.8 45 (8.3) 51 (9.4) -4.2
1.0 10 (1.8) 11 (2.0) -1.3
-18.5 53 (9.7) 57 (10.5) -2.6
g; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention.
TABLE 2 Angiographic and Procedural Characteristics
Total Population Propensity-Matched Population
FKB
(n ¼ 620)
Non-FKB
(n ¼ 1,281) p Value
Standardized
Difference
FKB
(n ¼ 545)
Non-FKB
(n ¼ 545) p Value
Standardized
Difference
Bifurcation location 0.002 0.52
Left main bifurcation 184 (29.7) 308 (24.0) 158 (29.0) 140 (25.7)
Left anterior descending artery/diagonal 342 (55.2) 704 (55.0) 0.4 304 (55.8) 327 (60.0) -8.5
Left circumﬂex/obtuse marginal artery 64 (10.3) 204 (15.9) -18.4 57 (10.5) 51 (9.4) 3.6
Right coronary artery bifurcation 30 (4.8) 65 (5.1) -1.1 26 (4.8) 27 (5.0) -0.9
Calciﬁcation, SB 35 (5.7) 61 (4.8) 0.410 3.8 30 (5.5) 26 (4.8) 0.68 3.2
Medina classiﬁcation <0.001 0.97
True bifurcation 310 (50.0) 452 (35.3) 260 (47.7) 259 (47.5)
1.1.1 203 (32.7) 260 (20.3) 164 (30.1) 164 (30.1)
1.0.1 47 (7.6) 79 (6.2) 5.3 41 (7.5) 38 (7.0) 2.1
0.1.1 60 (9.7) 113 (8.8) 2.9 55 (10.1) 57 (10.5) -1.2
Nontrue bifurcation 310 (50.0) 829 (64.7) 285 (52.3) 286 (52.5)
1.0.0 61 (9.8) 245 (19.1) -31.2 57 (10.5) 65 (11.9) -4.9
0.1.0 121 (19.5) 334 (26.1) -16.5 116 (21.3) 110 (20.2) 2.8
1.1.0 109 (17.6) 231 (18.0) -1.2 98 (18.0) 100 (18.4) -1.0
0.0.1 19 (3.1) 19 (1.5) 9.2 14 (2.6) 11 (2.0) 3.2
SB pre-dilation before MV stenting 146 (23.6) 190 (14.8) <0.001 20.5 116 (21.3) 110 (20.2) 0.71 2.6
Use of intravascular ultrasound 204 (32.9) 453 (35.4) 0.290 -5.2 179 (32.8) 190 (34.9) 0.52 -4.3
Total stent length, mm 27.7  11.7 28.8  12.6 0.13 -9.3 28.1  12.1 28.6  12.9 0.89 -3.5
Maximal stent diameter, mm 3.24  0.41 3.17  0.42 <0.001 15.8 3.23  0.41 3.21  0.42 0.70 3.9
Values are n (%) or mean  SD.
FKB ¼ ﬁnal kissing ballooning; MV ¼ main vessel; SB ¼ side branch.
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1301non-FKB group, those in the FKB group had a higher
prevalence of high left ventricular ejection fraction,
left main bifurcation lesion, true bifurcation, SB pre-
dilation, and large stent diameter. However, they had
a lower prevalence of left circumﬂex/obtuse marginal
artery bifurcation, as well as ST-segment elevation MI
and non–ST-segment elevation MI at initial presen-
tation. First-generation drug-eluting stents such as
the sirolimus-eluting stent and paclitaxel-eluting
stent were similarly implanted in both groups (464
patients [74.8%] in the FKB group and 942 [73.5%] in
the non-FKB group [p ¼ 0.54]). In addition, 109 pa-
tients (17.6%) in the FKB group and 235 (18.3%) in the
non-FKB group discontinued dual antiplatelet ther-
apy for <12 months; there was no signiﬁcant differ-
ence between the 2 groups (p ¼ 0.69).
Propensity-matched population. After propensity-score
matching for the entire population, 545 matched pairs
of patients were created (Tables 1 and 2). The C-statistic
for the propensity score model was 0.76, suggesting
that the use of FKB was relatively random; this im-
proves the reliability of our analysis. There were no
signiﬁcant differences in baseline, angiographic, or
procedural characteristics between the FKB and non-
FKB groups for propensity-matched subjects.
QUANTITATIVE CORONARY ANGIOGRAPHIC ANALYSIS.
Minimum intraobserver agreements of QCA variablesusing the intraclass coefﬁcient were 0.98 (H.C.G.) and
0.97 (J.H.Y.), and minimum interobserver variability
was 0.80. In the overall population, lesion length was
shorter and proximal RD was larger in the MV of the
FKB group than those of non-FKB group. Lesion
length was longer, distal RD was larger, and ostial
MLD was smaller in the SB of the FKB group
compared with those in the non-FKB group (Table 3).
After MV stenting (before FKB), the middle MLD of
the MV and the ostial MLD of the SB were signiﬁcantly
smaller in the FKB group. After FKB, the MV prox-
imal, middle, and distal MLD; SB ostial; and distal
MLD were signiﬁcantly larger in the FKB group than
in the non-FKB group. These QCA results after
FKB were maintained in the propensity-matched
populations.
CLINICAL OUTCOMES. Overall population. The median
follow-up duration was 36 months (interquartile
range: 25 to 50 months) and 152 MACE occurred.
Table 4 shows the cumulative clinical outcomes of the
study groups. The incidence of MACE was signiﬁ-
cantly lower in the FKB group than in the non-FKB
group (FKB vs. non-FKB: 6.8 vs. 8.6%; p ¼ 0.048)
(Figure 3A). The incidence of all-cause death, cardiac
death, and stent thrombosis was not signiﬁcantly
different between the 2 groups, but the incidence
of MI was (0.6% vs. 1.8%; p ¼ 0.03). In the
TABLE 3 QCA Data
Total Population Propensity-Matched Population
FKB
(n ¼ 620)
Non-FKB
(n ¼ 1,281) p Value
Standardized
Difference
FKB
(n ¼ 545)
Non-FKB
(n ¼ 545) p Value
Standardized
Difference
Baseline
Main vessel
Lesion length 17.10  11.0 18.20  11.78 0.05 -10.0 17.38  11.31 17.48  11.09 0.73 -0.9
Proximal RD 3.52  0.67 3.39  0.63 <0.001 20.4 3.50  0.66 3.44  0.66 0.74 7.6
Distal RD 2.76  0.48 2.71  0.48 0.06 9.4 2.74  0.48 2.74  0.49 0.97 0.2
Proximal MLD 1.75  0.91 1.75  0.97 0.92 -0.5 1.76  0.92 1.70  0.97 0.71 6.3
Middle MLD 1.35  0.66 1.41  0.74 0.07 -9.2 1.35  0.66 1.33  0.67 0.67 3.4
Distal MLD 1.92  0.79 1.72  0.84 <0.001 25.1 1.88  0.79 1.83  0.84 0.54 6.3
Side branch
Lesion length 3.71  5.33 3.03  5.73 0.01 12.7 3.64  5.42 3.62  5.61 0.87 0.4
Distal RD 2.60  0.42 2.55  0.43 0.02 11.6 2.59  0.42 2.55  0.45 0.29 10.2
Ostial MLD 1.57  0.74 1.71  0.71 <0.001 -19.0 1.59  0.75 1.57  0.71 0.89 2.9
Distal MLD 2.05  0.68 1.98  0.67 0.05 9.5 2.02  0.69 1.96  0.71 0.27 9.6
After MV stenting
Main vessel
Proximal MLD 3.07  0.54 3.05  0.57 0.66 2.2 3.07  0.55 3.02  0.58 0.85 9.2
Middle MLD 2.75  0.53 2.81  0.54 0.04 -10.1 2.76  0.54 2.71  0.56 0.72 9.6
Distal MLD 2.76  0.49 2.76  0.52 0.91 -0.6 2.76  0.49 2.72  0.54 0.85 8.6
Side branch
Ostial MLD 1.21  0.72 1.52  0.75 <0.001 -42.7 1.26  0.73 1.25  0.69 0.71 1.3
Distal MLD 2.02  0.68 1.99  0.65 0.36 4.4 2.02  0.69 1.96  0.68 0.67 7.8
Final
Main vessel
Proximal MLD 3.29  0.57 3.07  0.57 <0.001 3.27  0.57 3.04  0.59 <0.001
Middle MLD 2.87  0.50 2.81  0.53 0.03 2.86  0.50 2.72  0.56 0.001
Distal MLD 2.84  0.48 2.77  0.52 0.003 2.83  0.48 2.73  0.55 0.04
Side branch
Ostial MLD 1.84  0.62 1.58  0.73 <0.001 1.85  0.62 1.36  0.69 <0.001
Distal MLD 2.16  0.58 2.01  0.65 <0.001 2.15  0.59 1.99  0.68 0.04
Values are mean  SD.
MLD ¼ minimal lumen diameter; QCA ¼ quantitative coronary angiography; RD ¼ reference diameter; other abbreviations as in Tables 1 and 2.
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1302multivariable regression analysis, the FKB group had
a signiﬁcantly lower risk of MACE (adjusted hazard
ratio [HR]: 0.68; 95% conﬁdence interval [CI]: 0.46 to
0.99; p ¼ 0.048), but the incidence of MI was not
signiﬁcantly different between the 2 groups (Table 4).
The deﬁnite or probable stent thrombosis rate was
not signiﬁcantly different between the groups (0.5%
vs. 0.3%; p ¼ 0.72).
Propensity-matched population. After 1:1 propensity-
score matching, FKB was associated with a lower
incidence of MACE (6.8% vs. 9.7%; adjusted HR:
0.50, 95% CI: 0.30 to 0.85; p ¼ 0.01) and TLR (5.9%
vs. 7.9%; adjusted HR: 0.51, 95% CI: 0.28 to 0.91;
p ¼ 0.02) (Table 5, Figure 3B). However, the inci-
dence of MI was not signiﬁcantly different between
the 2 groups. The incidence of TLR in the MV (5.7%
vs. 7.3%; adjusted HR: 0.51, 95% CI: 0.28 to 0.93;
p ¼ 0.03) and in both vessels (4.2% vs. 7.0%;
adjusted HR: 0.47, 95% CI: 0.25 to 0.90; p ¼ 0.02)was lower in the FKB group. The rate of TLR at the
SB was also numerically lower in the FKB group but
was not signiﬁcantly different between the 2
groups. There was no signiﬁcant clinical center ef-
fects (p values ranging from 0.117 to w0.527).
Subgroup analys i s . To determine whether the
observed outcomes related to FKB in the overall and
propensity-matched populations were consistent,
we calculated the unadjusted HR for MACE in
various complex subgroups (Figure 4). There were no
signiﬁcant interactions between the use of FKB and
MACE among all the subgroups. Compared with the
non-FKB group, the association of FKB with better
MACE outcome was consistent across various sub-
groups including women and patients with acute coro-
nary syndrome, non–left main bifurcation lesions, and
true bifurcations; these associations were also con-
sistent in propensity-matched population subgroups
(Figure 5).
TABLE 4 Clinical Outcomes in FKB Group Compared With Non-FKB Group During Follow-Up Period
FKB
(n ¼ 620)
Non-FKB
(n ¼ 1,281)
Unadjusted HR
(95% CI) p Value
Adjusted HR*
(95% CI) p Value
All-cause death 19 (3.1) 42 (3.3) 0.86 (0.50–1.48) 0.59 0.86 (0.47–1.58) 0.63
Cardiac death 4 (0.6) 15 (1.2) 0.53 (0.18–1.60) 0.26 0.56 (0.17–1.90) 0.35
MI 4 (0.6) 23 (1.8) 0.32 (0.11–0.91) 0.03 0.48 (0.16–1.45) 0.19
Stent thrombosis† 3 (0.5) 4 (0.3) 1.50 (0.34–6.71) 0.60 1.36 (0.25–7.28) 0.72
Target lesion revascularization 36 (5.8) 84 (6.6) 0.78 (0.53–1.16) 0.22 0.71 (0.47–1.09) 0.12
Main vessel 35 (5.6) 81 (6.3) 0.79 (0.53–1.17) 0.24 0.71 (0.46–1.09) 0.11
Side branch 13 (2.1) 28 (2.2) 0.85 (0.44–1.64) 0.62 0.67 (0.33–1.38) 0.28
Both vessels 25 (4.0) 66 (5.2) 0.70 (0.44–1.11) 0.13 0.66 (0.40–1.08) 0.10
MACE‡ 42 (6.8) 110 (8.6) 0.70 (0.49–0.99) 0.048 0.68 (0.46–0.99) 0.048
Values are n (%) unless otherwise indicated. *Adjusted covariates include age, diabetes mellitus, left ventricular ejection fraction, clinical manifestation, bifurcation location,
Medina classiﬁcation, SB pre-dilation before main vessel stenting, proximal reference diameter of MV, distal MLD of MV, lesion length of SB, distal RD of SB, ostium MLD of
SB, middle MLD of MV after MV stenting, and ostium MLD of SB after MV stenting. †Stent thrombosis was deﬁned as deﬁnite or probable. ‡Major adverse cardiac events
included cardiac death, recurrent MI, and target lesion revascularization.
CI ¼ conﬁdence interval; HR ¼ hazard ratio; MACE ¼ major adverse cardiac events; other abbreviations as in Tables 1 to 3.
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1303DISCUSSION
In the present study,we investigated the association of
FKB with clinical outcome in patients with coronary
bifurcation lesions treated with the 1-stent technique
using data from a large, multicenter registry in Korea.
The FKB group had a lower risk of MACE than did the
non-FKB group. This result was maintained in
propensity-matched populations and was mainly
driven by a reduction of TLR in the main vessel or in
both vessels (the MV and the SB). Furthermore, the
association of FKB with favorable MACE outcome was
consistent across various subgroups. However, there
were no signiﬁcant differences between the groups in
terms of the rates of hard endpoints such as cardiac
death, MI, or stent thrombosis.FIGURE 3 Unadjusted Kaplan-Meier Curves in FKB Versus Non-FKB
(A) Kaplan-Meier curves for major adverse cardiac events (MACE) in ﬁna
(dashed line) in all patients. (B) Kaplan-Meier curves for MACE in FKB vThe provisional stenting technique remains the
preferred strategy in the majority of coronary
bifurcation lesions based on several randomized
controlled trials and meta-analyses, although the
optimal stenting technique for bifurcation lesions has
been debated (1,4,13). It is not known whether the
MV stent should always be opened at the SB ostium by
FKB in cases in which decreased TIMI ﬂow or severe
dissection do not occur in the SB. In addition, the re-
sults regarding geometric change after SB opening
through MV stent from observational studies are
inconsistent (14–16). Meticulous bench testing by
Ormiston et al. (14) demonstrated that balloon dilation
through the struts of a stent distorted the stent and
induced stenosis in the stent immediately distal to the
SB, which was restored by simultaneous FKB using anGroups
l kissing ballooning (FKB) (solid line) versus non-FKB groups
ersus non-FKB groups in propensity-matched populations.
TABLE 5 Clinical Outcomes in FKB Group Compared With Non-FKB Group in Propensity-Matched Population During Follow-Up Period
FKB
(n ¼ 545)
Non-FKB
(n ¼ 545)
Unadjusted HR
(95% CI) p Value
Adjusted HR*
(95% CI) p Value
All-cause death 17 (3.1) 20 (3.7) 0.67 (0.30–1.48) 0.32 0.68 (0.28–1.63) 0.39
Cardiac death 3 (0.6) 8 (1.5) 0.43 (0.11–1.66) 0.22 0.50 (0.11–2.29) 0.37
MI 4 (0.7) 5 (0.9) 0.50 (0.09–2.73) 0.42 0.18 (0.01–20.36) 0.48
Stent thrombosis† 3 (0.6) 4 (0.7) 0.72 (0.16–3.23) 0.67 0.77 (0.17–3.45) 0.73
Target lesion revascularization 32 (5.9) 43 (7.9) 0.53 (0.30–0.94) 0.03 0.51 (0.28–0.91) 0.02
Main vessel 31 (5.7) 40 (7.3) 0.53 (0.30–0.96) 0.04 0.51 (0.28–0.93) 0.03
Side branch 12 (2.2) 18 (3.3) 0.57 (0.24–1.36) 0.21 0.57 (0.24–1.37) 0.21
Both vessels 23 (4.2) 38 (7.0) 0.47 (0.25–0.88) 0.02 0.47 (0.25–0.90) 0.02
MACE‡ 37 (6.8) 53 (9.7) 0.54 (0.32–0.89) 0.02 0.50 (0.30–0.85) 0.01
Values are n (%) unless otherwise indicated. *Adjusted covariates include hypertension, history of coronary artery bypass graft, and distal RD of SB. †Stent thrombosis
was deﬁned as deﬁnite or probable. ‡Major adverse cardiac events included cardiac death, recurrent MI, and target lesion revascularization.
Abbreviations as in Tables 1 to 4.
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1304in vitro model. In addition, comprehensive volumetric
intravascular ultrasound studies demonstrated that,
in the bifurcation lesion, SB dilation signiﬁcantly
reduced the MV stent volume area under the SB origin
and distorted MV stent symmetry, which was restored
after FKB (16). In a previous study, dilation of the SB
actually resulted in a reduction in the cross-sectional
area under the SB origin from 5.9  1.2 mm2 initiallyFIGURE 4 Comparative Unadjusted HR of MACE for Subgroups in Al
There were no signiﬁcant interactions between the use of FKB and MACE
HR ¼ hazard ratio; MACE ¼ major adverse cardiac event(s); other abbreto 5.2  1.2 mm2. After KB inﬂation, the cross-sectional
area partially recovered (to 5.6  1.2 mm2) (15). More-
over, our ﬁnal QCAdata showed that proximal, middle,
and distal MLD in theMV and SBwere larger in the FKB
group compared with those in the non-FKB group.
These results suggest that FKBmight reduce the rate of
in-stent restenosis and subsequently the rate of TLR by
increasing luminal gain in the MV and SB.l Populations
among various subgroups in all populations. CI ¼ conﬁdence interval;
viations as in Figure 1.
FIGURE 5 Comparative Unadjusted HR of MACE for Subgroups in Propensity-Matching Population
There were no signiﬁcant interactions between the use of FKB and MACE among various subgroups in propensity-matching populations.
Abbreviations as in Figures 1, 3, and 4.
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1305Until now, the beneﬁt of FKB has been demonstrated
only in bifurcation lesions treated with the 2-stent tech-
nique, mostly using the culotte or crush technique
(5,6,17). Therefore, several clinical studies have investi-
gated both the clinical and angiographic effects of routine
FKB in patients with coronary bifurcation lesions
treated with the 1-stent technique (2,7–9). However,
these studies have reported conﬂicting results. Our pre-
vious study (COBIS I) reported that FKB increased
the long-term risk of TLR, most of which occurred in the
MV and may have harmed the MV stent (7). The current
study (COBIS II) included 492 patients (17%) who were
enrolled in COBIS I. The COBIS II study included coronary
bifurcation lesions with a larger size of MV and SB
compared with the COBIS I study. The big difference
between the COBIS II and COBIS I studies in terms of
clinical outcomes is that, in the FKB group, the incidence
of TLR in the MV and in both vessels was lower in the
COBIS II study, in contrast to the higher incidence of TLR
in the COBIS I study. These contrary results can be
attributed to several factors. First, after FKB, the MV
middle and distal MLD was not different between the
FKB and non-FKB groups in the COBIS I study, but was
larger in the FKB than non-FKB group in the COBIS IIstudy. FKB appears to make less of a difference inMLD in
smaller vessels, whereas dilation of larger vessels with a
larger balloon produces a bigger luminal gain. If FKB
causes MV stent deformity and subsequently increases
the incidence of binary restenosis in MV stents, the pos-
sibility of ischemia-driven TLR would be higher in the
FKB group with same-sized MLD. However, in cases of a
larger MLD with FKB, the inﬂuence of binary restenosis
by stent deformity might be relatively small because a
similar degree of late loss produces greater diameter
stenosis in smaller lumens than in larger ones. Both
studies obviously showed that SB ostial and distal
MLD after FKB increased in the FKB group, but found
no signiﬁcant difference in TLR of the SB between
FKB and non-FKB groups. Koo et al. (18) reported that
diagonal branch occlusion caused fewer symptoms,
fewer electrocardiogram changes, less arrhythmogenic
potential, and better collateral recruitability than left
anterior descending artery occlusion did. Our study
included more than 50% of left anterior descending
artery/diagonal bifurcation lesions. Therefore, we sug-
gest that restenosis of SB may not translate into
ischemia-driven TLR, which is why there was no sig-
niﬁcant difference in terms of TLR of the SB between
PERSPECTIVES
WHAT IS KNOWN? Although FKB is currently
considered mandatory in 2-stent techniques, the
effects of FKB on clinical and angiographic outcomes
after only MV stenting are controversial. In addition,
most relevant studies are limited by small sample size,
an inadequate short-term follow-up period, exclusion
of left main bifurcation lesions, or a small SB.
WHAT IS NEW? In coronary bifurcation lesions,
we demonstrated that the 1-stent technique with
FKB was associated with a favorable long-term clinical
outcome, mainly driven by the reduction of TLR
in the MV or both vessels as a result of an increase in
MLD.
WHAT IS NEXT? Angiographic follow-up and
TLR were performed according to each institution’s
strategy and each operator’s discretion. Therefore,
our results need to be conﬁrmed in a future
prospective randomized trial.
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1306both groups even though post-MLD of SB was larger in
the FKB group than in the non-FKB group.
STUDY LIMITATIONS. First, the nonrandomized nature
of the registry data could have resulted in selec-
tion bias. Several baseline characteristics were
signiﬁcantly different between groups, and the deci-
sion to perform FKB in each patient was made at the
operator’s discretion. Although we performed a pro-
pensity score-matched analysis to adjust for these
potential confounding factors, we were not able to
correct for unmeasured variables. Second, angio-
graphic follow-up and TLR were performed according
to each institution’s strategy and each operator’s
discretion. In particular, we did not know the rela-
tionship between binary restenosis and TLR because
we did not have information on intravascular ultra-
sound before and after FKB or at follow-up angiog-
raphy. Third, adverse clinical events were not
centrally adjudicated in our registries. All events
were identiﬁed by the patients’ physicians and
conﬁrmed by the principal investigator of each hos-
pital. Fourth, the results of stent thrombosis in the
present study should be considered cautiously.
Although the vital status of all patients, including
those lost to follow-up, was conﬁrmed with the
Korean national database using a citizen registration
number that is unique to each individual, we cannot
exclude the possibility of under-reporting of clinical
outcomes other than death such as nonfatal MI and
stent thrombosis. Fifth, in real-world practice, there
are considerations of strategy and timing of
FKB depending on the preference of the operator.
Accordingly, in a substantial portion treated without
previously enlarging the stent struts with a single
balloon, TLR might not be associated with the
geometrical distortion of the stent struts. Sixth, given
the observed clinical event rates, a properly powered
study would include more than 7,461 patients (FKB
vs. non-FKB, a-error: 0.05, b-error: 0.2). Accordingly,
the study was considerably underpowered and sub-
group analysis was not conclusive. Lastly, the out-
comes of FKB with second- or third-generation stents
because of improved SB access will need to be tested
in a future trial.CONCLUSIONS
In a large, multicenter Korean registry trial studying
coronary bifurcation lesions, we demonstrated that
the 1-stent technique with FKB was associated with a
favorable long-term clinical outcome, mainly driven
by the reduction of TLR in the MV or both vessels as a
result of an increase in MLD. These ﬁndings need to
be conﬁrmed in a future large-scale randomized trial.
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